Cited by 49Genomics, phytochemicals, and oxidative stressSkin Protection and AgingAdvancements in Transdermal Drug Delivery

Skin Redox Balance Maintenance: The Need for an Nrf2-Activator Delivery System

Open access
Ben-Yehuda Greenwald, Maya, Ben-Sasson, Shmuel, Bianco-Peled, Havazelet, Kohen, Ron·2016·Cosmetics

Abstract

The skin, being the largest organ of the body, functions as a barrier between our body and the environment. It is consistently exposed to various exogenous and endogenous stressors (e.g., air pollutants, ionizing and non-ionizing irradiation, toxins, mitochondrial metabolism, enzyme activity, inflammatory process, etc.) producing reactive oxygen species (ROS) and physical damage (e.g., wounds, sunburns) also resulting in reactive oxygen species production. Although skin is equipped with an array of defense mechanisms to counteract reactive oxygen species, augmented exposure and continued reactive oxygen species might result in excessive oxidative stress leading to many skin disorders including inflammatory diseases, pigmenting disorders and some types of cutaneous malignancy. The nuclear factor erythroid 2-related factor 2 (Nrf2) is an emerging regulator of cellular resistance and of defensive enzymes such as the phase II enzymes. Induction of the Keap1–Nrf2 pathway may have a beneficial effect in the treatment of a large number of skin disorders by stimulating an endogenous defense mechanism. However, prolonged and enhanced activation of this pathway is detrimental and, thus, limits the therapeutic potential of Keap1–Nrf2 modulators. Here, we review the consequences of oxidative stress to the skin, and the defense mechanisms that skin is equipped with. We describe the challenges of maintaining skin redox balance and its impact on skin status and function. Finally, we suggest a novel strategy for maintenance of skin redox homeostasis by modulating the Keap1–Nrf2 pathway using nanotechnology-based delivery systems.

Integrity signals

Registry

Crossref · 10.3390/cosmetics3010001

Cites

238 of 238 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

1 retracted

Flagged first, then by citations

7 of the 245 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Ben-Yehuda Greenwald, M., Ben-Sasson, S., Bianco-Peled, H., & Kohen, R.
Affiliations
  • The David and Ines Myers Skin Research Laboratory, The Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem 9112100, Israel
  • Department of Developmental Biology and Cancer Research, The Hebrew University Medical School, Ein-Karem Campus, Jerusalem 9112100, Israel
  • Department of Chemical Engineering, Technion-Israel Institute of Technology, Technion City, Haifa 3200003, Israel
  • Hebrew University of Jerusalem (IL)
Corresponding author
Kohen, Ron
Venue
Cosmetics
Publisher
MDPI AG
Published
2016-01-15
Volume
3
Issue
1
Pages
1
ISSN
2079-9284 (ISSN-L)
OpenAlex
W2239904501
Cited by
49
References
245
Citations by year
2026: 1 · 2025: 2 · 2023: 2 · 2022: 3 · 2021: 8 · 2020: 13 · 2019: 8 · 2018: 8 · 2017: 2 · 2016: 2
FWCI
3.47
Type
journal article
Language
en
Open access
Locations
  • Cosmetics (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
  • Health Sciences › Medicine › Dermatology › Skin Protection and Aging
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
Nrf2, Nrf2/Keap1 pathway, oxidative stress, reactive oxygen species, nanotechnology-based drug delivery, skin diseases, phase II enzymes, skin cancer, skin barrier

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review